| MCL1 | Myeloid cell leukemia sequence 1 |
| BCL2 | B-cell CLL/lymphoma 2 |
| BIM | BCL2-like 11 (apoptosis facilitator) |
| PARP | Poly ADP-ribose polymerase 1 |
| NOXA | Phorbol-12-myristate-13-acetate-induced protein 1 |
| BID | BH3 Interacting Domain Death Agonist |
| CASP8 | Caspase 8 |
| PDCD4 | Programmed cell death protein 4 |
| CRISPR | Clustered regularly interspaced short palindromic repeats |
| BRAF | B-Raf proto-oncogene |
| BH3 | Bcl-2 Homology 3 |
| ABT-199 | Abbott Laboratories, a Bcl-2 selective BH3 mimetic |
| FDA | U.S. Food and Drug Administration |
| RAS | Rat sarcoma family of oncogenes |
| NF1 | Neurofibromin 1 |
| NRAS | Neuroblastoma RAS Proto Oncogene |
| SEM | Standard error of the mean |
| MEK | Mitogen-activated protein kinase family |